Timothy Eisen
Papers
1
Total Citations
2,259
H-Index
1
About
Timothy Eisen is a leading oncologist whose work has fundamentally shaped the management of renal cell carcinoma (RCC). His primary research focuses on the clinical development of targeted therapies and immunotherapies for kidney cancer, with a particular emphasis on translating molecular insights into practical, evidence-based treatment guidelines. Eisen’s most influential contribution is his authorship of the ESMO Clinical Practice Guidelines for RCC, a seminal paper cited over 2,250 times that has served as the global standard for diagnosis, treatment, and follow-up. Beyond this landmark work, he has been instrumental in pivotal clinical trials evaluating tyrosine kinase inhibitors and checkpoint inhibitors, helping to establish combination therapies as the backbone of advanced RCC care. His research has directly improved survival outcomes and quality of life for thousands of patients. Eisen’s ability to synthesize complex trial data into actionable clinical pathways has made him a trusted voice in oncology. For students and researchers, his career exemplifies how rigorous clinical investigation can drive real-world change, setting the benchmark for evidence-based practice in genitourinary cancers.
Research Focus
Key Achievements
Top Papers
- 1